Cervical Dysplasia Market (Diagnostics Type - HPV Test, Pap Smear Test, Biopsy, and Colposcopy; Treatment Type - Surgery, Chemotherapy, Therapeutic HPV Vaccines, Radiation Therapy, and Other Treatment Types; End Users - Hospitals, Diagnostic Centers, Ambulatory Surgery Centers, Specialty Clinics, and Research & Academic Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

A recent report published by Infinium Global Research on cervical dysplasia market provides an in-depth analysis of segments and sub-segments in the global as well as regional cervical dysplasia market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cervical dysplasia market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cervical dysplasia market. According to the report, the global cervical dysplasia market is projected to grow at a healthy CAGR over the forecast period of 2019-2025.

Market Insight

Cervical dysplasia is a precancerous condition in which abnormal development of cells is found on the cervix. It is also known as cervical intraepithelial neoplasia (CIN). Women of any age can develop cervical dysplasia, it is more frequent in between 25 to 35 years of age in women. Cervical dysplasia can be cured before it becomes cancerous by proper treatment and regular diagnosis. Cervical dysplasia is usually caused by Human papillomavirus. HPV is a sexually transmitted virus which causes tumors and warts. Cervical dysplasia does not show any symptoms they are asymptomatic. Cervical dysplasia is diagnosed by Pap test, HPV tests, and colposcopy. Cervical dysplasia is treated by destruction and removal of the abnormal area. Both types of treatment are equally effective. Further, cryosurgery, loop electrosurgical procedure, laser surgery, and cold knife cone biopsy are performed when diagnosed with cervical dysplasia.

The rising awareness about cervical cancer is driving the growth of cervical dysplasia market. According to WHO, cervical cancer is the fourth most frequent cancer in women. Approximately, 570,000 new cases of cervical cancer were reported in 2018. In addition, government initiatives on social mobilization, vaccination, screening, and community education have led to an increase in the diagnosis of cervical dysplasia. Further, the rising occurrence of HPV infection is driving the growth of cervical dysplasia market. However, unavailability of a therapeutic drug due to time-consuming regulatory compliance, pending approvals and the high cost required for research and development in the market for cervical dysplasia is restraining the growth of cervical dysplasia market. Moreover, the market for therapeutic drugs and supportive care drugs is likely to rise in the future owing to a large number of ongoing research and development for the treatment of cervical dysplasia.

Among the regions, North America holds the largest share in cervical dysplasia market. The growing occurrences of cervical dysplasia, the growing awareness about cervical cancer and supportive government reimbursement policies are contributing to the growth of the cervical dysplasia market. Europe holds the second largest share in cervical dysplasia market due to heavy investment in research and development in the healthcare sector. Asia Pacific region is anticipated to grow at the fastest rate in cervical dysplasia market due to the high prevalence of HPV infection. Additionally, the growing healthcare, increasing consciousness about cervical dysplasia among woman and increasing awareness programs are driving the growth of cervical dysplasia market in the Asia Pacific region.

Segment Covered

The report on global cervical dysplasia market covers segments such as diagnostics type, treatment type, and end users. On the basis of diagnostics type, the sub-markets include HPV test, pap smear test, biopsy, and colposcopy. On the basis of treatment type, the sub-markets include surgery, chemotherapy, therapeutic HPV vaccines, radiation therapy, and other treatment types. On the basis of end users, the sub-markets include hospitals, diagnostic centers, ambulatory surgery centers, specialty clinics, and research & academic institutes.

Companies Profiled:

The report provides profiles of the companies in the market such as GlaxoSmithKline Plc., Qiagen N.V., Becton, Dickinson and Company, Quest Diagnostics, Inc., Abbott Laboratories, F. Hoffmann La-Roche Ltd., Hologic, Inc., OncoHealth Corporation, and Other Companies.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cervical dysplasia market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.